Agenda

DAY 1: THURSDAY, APRIL 19, 2012 

PRE-CONFERENCE

8:00 a.m.–12:00 p.m. (6 concurrent sessions — choose one)

 

SESSION 1: Dressings: A to Z
Moderator/Speaker: Bonnie Sue Rolstad, RN, MS, CWOCN
Speakers: JoAnn Ermer-Seltun, RN, MS, ARNP, CWOCN;Debra Netsch, DNP, APRN, CNP, CWOCN
Dressing materials are hot topics in wound care. Their role in establishing and maintaining an optimal wound environment with an intentional focus on infection control will be emphasized by the faculty. Interactive clinical case studies, a product formulary and a hands-on session with commonly used dressings will be included in this session. 

SESSION 2: WHS — Wound Healing Basics
Moderator/Speaker: Lynne M. Grant, MS, RN, CWOCN
Speakers: Barbara Bates-Jensen, PhD, RN, FAAN; Linda J. Cowan, MSN, ARNP, CWS; Lisa Gould, MD, PhD; Harvey Himel, MD; Arti B. Masturzo, MD, CWS, ABPM/UHM; Gregory Schultz, PhD
This is a clinically oriented session focused on the basic principles and practices of wound care designed to benefit healthcare professionals new to the wound care field, all trainees studying wound healing, and all individuals involved in wound care. This session will focus on the core competencies of wound care, including the basics of normal wound healing, impediments to healing, and wound assessment. Evidence-based treatment guidelines for pressure ulcers and lower extremity chronic wounds will be presented. 

SESSION 3: Understanding Vascular Assessment
Moderator/Speaker: John C. Lantis, MD, FACS
Speakers: Mark D. Iafrati, MD; Evan Lipsitz, MD
This session will provide an algorithm for the comprehensive vascular assessment of the patient with extremity wounds, focusing on all aspects of vascular assessment from the reliability and cost effectiveness of history and physical exam to advanced radiologic imaging. There will be a strong focus on the roles of non-invasive physiologic testing and transcutaneous oxygen testing. A pathway for the use and indications of ultrasound diagnostic imaging, especially in the patient with chronic disease, will be outlined. Choices and interpretation of imaging results including computerized axial tomography, magnetic resonance imaging and invasive imaging of both the arterial and venous tree will be defined. The role of nuclear medicine in lymphatic assessment will be explored. Finally, emerging assessment techniques — including laser Doppler, near infrared spectroscopy, and metabolic-based photography — will be discussed.

SESSION 4: Clinical Assessment: Pathway to Wound Diagnoses and Treatment
Moderator/Speaker: Dot Weir, RN, CWOCN, CWS
Speaker: Walter A. Conlan, III, MD, CWS ; Han Hulen, MD
Participants will be led through a series of case presentations on the clinical assessment of the patient with a wound from diagnosis to treatment. A clinical workshop on incorporating available evaluation and management tools into practice will follow. 

SESSION 5: Making Wound Healing Work — Running a Successful Clinic
Moderator/Speaker: D. Scott Covington, MD, FACS, CHWS
Speakers: Arti B. Masturzo MD CWS ABPM/UHM; Thomas E. Serena, MD, FACS, MAPWCA, FACHM; Debra Stewart, MD
Given the aging population and their associated comorbidities, delivering accurate, cost-effective wound care has never been more important. This session will focus on the process from the perspective of today’s wound care center. Specifically, clinic operations and healing strategies will be analyzed in light of the information management tools and financial considerations necessary to run a successful center.

WHS PROGRAM: SESSION A (Pre-Conference) (Non-Accredited)
8:00 a.m.–12:00 p.m.
Due to the thought-provoking and brainstorming-discussion format of this session, there will be no CE accreditation.
Pre-Clinical Models of Wound Healing
Moderators: Andrew Baird, PhD; Gayle Gordillo, MD, FACS
Speakers: Elof Eriksson, MD; Boris Hinz, PhD; Gayle Gordillo, MD, FACS
This pre-conference session is aimed at providing attendees with a review of current use of animal and human models to study wound healing with emphasis to the specific use: basic science and/or clinical and translational.

BREAK 12:00 p.m.–12:30 p.m.

 

INDUSTRY-SUPPORTED SYMPOSIA 12:30 p.m.–2:00 p.m.

 

BREAK 2:00 p.m.–2:15 p.m.

 

OPENING CEREMONY 2:15 p.m.– 3:00 p.m.

 

GENERAL SESSION: OPENING KEYNOTE ADDRESS

3:00 p.m.–4:00 p.m.

Personalized Medicine: Today and Tomorrow

 

BREAK 4:00 p.m.–4:15 p.m.

 

4:15 p.m.–5:15 p.m. (7 concurrent sessions — choose one)

 

SESSION 6: Core Clinical

Demography and Epidemiology of Wounds: The Epidemic Continues
Moderator/Speaker: David J. Margolis, MD, PhD
Like epidemiology, demography is the study of the human populations. However, as compared to epidemiology, demography evaluates the distribution of population characteristics with respect to spatial and temporal changes and correlations. This session will primarily focus on demographic associations described in those with diabetic foot ulcers and lower extremity amputations.

 

SESSION 7: Advanced Clinical

Advanced Pearls: Rapid-Fire Clinically Relevant information
Moderator/Speaker: Susie Seaman, NP, MSN, CWOCN
Speakers: Gerit Mulder, DPM, MS, PhD(c), FRCST, FAPWCA; Tania Phillips, MD; Pamela Scarborough, PT, MS, CDE, CWS, FACCWS; Thomas E. Serena, MD, FACS, MAPWCA, FACHM
This stimulating session will be presented by a panel of five interdisciplinary wound care experts from nursing, physical therapy, podiatry, medicine and surgery. Each expert will discuss two concise pearls from their practice aimed at broadening participants' knowledge in the assessment and care of patients with chronic wounds.

 

SESSION 8: Wound Therapeutics

Nutrition and Wound Healing for the Overweight and Obese Patient
Moderator/Speaker: Liz Friedrich, MPH, RD, CSG, LDN
Patients who are overweight or obese may have a less than desirable body composition, poor eating habits, and inadequate physical activity, making wound healing difficult. This session will explore nutrition interventions to promote wound healing in those with a BMI of > 30. 

 

SESSION 9: Limb Preservation

Medical Approaches to Peripheral Arterial Disease
Moderator/Speaker: Dan Federman, MD
Speaker: Alan Dardik, MD, PhD
Those involved in wound healing encounter patients with ulcers caused by peripheral arterial disease (PAD). In this session, the epidemiology of PAD, evidence-based, non-surgical therapies aimed at decreasing overall risk, as well as important recent publications in the field will be discussed.

 

SESSION 10: Delivery of Wound Care

Providing Wound Care Under Parallel Reimbursement Programs: Traditional Medicare and ACOs
Moderator/Speaker: Kathleen D. Schaum, MS
This session will help wound care providers learn how to work under parallel Medicare reimbursement programs: 1) the traditional Medicare fee-for-service programs for physicians, hospitals, hospital outpatient wound care departments, skilled nursing facilities, home health agencies, and durable medical equipment suppliers; and 2) the Accountable Care Organizations that will be looking for excellent cost-effective wound care outcomes across various sites of service.  

SESSION 11: Research to Practice

“Hot Off the Press” Clinic Trials in Wound Healing
Moderator/Speaker: William Marston, MD
Speakers: Due to the late-breaking nature of this session, speakers will be identified closer to the meeting date.
In this session, results from important recent clinical trials of novel therapies for the treatment of chronic wounds will be presented. Preference for this session will be given to the most recent, cutting-edge study results in the development of new treatments for chronic, non-healing wounds. 

 

WHS Program: Session B

Infection and Biofilms
Moderators: Thomas Mustoe, MD; Randall D. Wolcott, MD
Speakers: Scot E. Dowd, PhD; Gregory Schultz, PhD; Daniel Wozniak, PhD

This session will feature lectures addressing the molecular and cellular basis of wound infection, current updates on the sciences of wound biofilm and therapies targeting wound infection and biofilm. 

BREAK 5:15 p.m.–5:30 p.m.

 

GRAND OPENING OF EXHIBITS/COCKTAIL RECEPTION

5:30 p.m.–8:30 p.m.

 

DAY 2:  FRIDAY, APRIL 20, 2012

 

POSTER SESSION/INDUSTRY-SUPPORTED SYMPOSIA

7:30 a.m.–9:00 a.m.

 

BREAK 9:00 a.m.–9:15 a.m.

 

9:15 a.m.–10:15 a.m. (7 concurrent sessions — choose one)

 

SESSION 12: Core Clinical

An Ounce of Prevention Equals More Than a Pound of Cure
Moderator/Speaker: Laurie McNichol, MSN, RN, GNP, CWOCN
Speaker: Catherine Ratliff, PhD, APRN-BC, CWOCN, CFCN
Healthcare providers have been discussing pressure ulcer prevention for over 25 years. In the National Pressure Ulcer Advisory Panel (NPUAP) monograph, Pressure Ulcers in America 2nd Edition (2012), the NPUAP reviews critical interventions on pressure ulcer prevention and highlights the current evidence on risk assessment scales and risk factors for developing pressure ulcers. As the lead authors on the pressure ulcer prevention chapter, the faculty will also identify areas in pressure ulcer prevention that need additional research. Don’t miss this opportunity to see if your prevention program is providing more than a pound of cure! 

 

SESSION 13: Advanced Clinical

Violence and Wounds: The Impact of Combat Wounds and Gang Violence
Moderator/Speaker: Michel Aboutanos, MD, MPH, FACS
This compelling presentation will discuss the fallout of gang violence as it relates to traumatic wounds and ostomies, and will show a powerful “in your face” understanding of the “hidden” problem all around the U.S.

 

SESSION 14: Wound Therapeutics

Dressings 2012: What Does the Future Hold for Wound Dressings?Moderator/Speaker: Professor Patricia M. Mertz
Speakers: Gregory Bohn, MS, MD, FACS; Tom Alan Wolvos, MD, FACS
This session will provide an overview of current wound dressings, what is new in FDA approved dressings and dressings in development. A unique look into the future will be presented: “When dressings do more than cover the wound.”

 

SESSION 15: Limb Preservation

Is this Osteomyelitis and Now What?
Moderator/Speaker: John H. Samies, MD, FSHEA, CWS
The diagnosis and management of osteomyelitis are common and complex topics faced by wound care professionals. The goals, timing and aggressiveness of treatment are often misunderstood by patients and clinicians alike, leading to unreasonable expectations. This session will explore accurate diagnosis and goal-directed therapy that are essential to successful patient-centered outcomes. 

 

SESSION 16: Delivery of Wound Care

The Wounded Psyche: The Brain Wound Continuum
Moderator/Speaker: Renee Cordrey, PT, MSPT, MPH, CWS
Speaker: Kathi L. Heffner, PhD
In wound healing, we advocate treating “the whole patient, not just the whole in the patient,” but are just starting to understand the mind-body connection. This session will begin with an overview of how the mind, immunity, hormones and tissue repair are linked. The second half will address clinical implications.

 

SESSION 17: Research to Practice

Angiogenesis: What Starts, Maintains and Reverses Blood Vessel Growth
Moderator/Speaker: Jeffrey M. Davidson, PhD
New blood vessel growth and regression are essential to normal tissue repair. Are there “stop signals”? This session will review the mechanisms and factors that turn neovascularization on and off in health and disease. Evidence that impaired vascularization is due to insufficient activation versus excess inhibition will be analyzed.

 

WHS Program: Session C

9:15 a.m.–11:30 a.m.

Young Investigators’ Symposium
Moderators: Luisa DiPietro, DDS, PhD; Harriet W. Hopf, MD
The symposium will feature presentations by young investigators who received the highest peer review scores for their abstracts. The session is designed as a competition to recognize and promote young scientists in the field of wound healing and related areas, and is a highlight of the WHS Annual Meeting.

 

BREAK 10:15 a.m.–10:30 a.m.

 

10:30 a.m.–11:30 a.m. (6 concurrent sessions — choose one)

 

SESSION 18: Core Clinical

Hot Topics in Pressure Ulcers: Perioperative Pressure Ulcers, Deep-Tissue injury and Beyond
Moderator/Speaker: Mona Baharestani, PhD, APN, CWON, CWS
Speakers: Joyce M. Black, PhD, RN, CPSN, SWCN, FAAN; Ann Marie Nie, MSN, CNP, CWOCN
Using a case-based approach, this interactive panel presentation will provide attendees with insight into the literature, cutting edge research and practical interventions focusing on the: (1) reduction of perioperative pressure ulcers; (2) diagnosis and management of suspected deep tissue injuries; as well as (3) prevention and treatment of medical device related pressure ulcers across the lifespan. 

 

SESSION 19: Advanced Clinical

The Role of Bacteria in Wound Healing
Moderator/Speaker: Gerald S. Lazarus, MD, FACP, FAAD
Speaker: Jonathan M. Zenilman, MD
There is a revolution in microbiology due to the use of genomic methods and the demonstration of biofilms in wounds. The use of these genomic methods have demonstrated a broad array of bacteria in wounds and especially the presence of anaerobic organisms in biofilms. This session will explain the importance of these new findings and will also discuss the appropriate use of antibiotics depending upon the profile of organisms. There is a critical need to analyze the correct approach for antibiotics in the therapy of chronic wounds. 

SESSION 20: Wound Therapeutics

Wheelchairs: Biomechanics Put to Practice
Moderator/Speaker: Stephen Sprigle, PhD, PT
Speaker: Thomas J. Whelan
This session will provide a comprehensive overview on current research and technology in the area of seating and mobility with an emphasis on pressure ulcer prevention. Topics of discussion will include postural biomechanics, wheelchair configuration, wheelchair cushion design and interface pressure measurement. 

 

SESSION 21: Limb Preservation

Hyperbaric Oxygen Therapy: Science to Practice
Moderator/Speaker: Tania Phillips, MD
Speakers: Lee J. Goldstein, MD; Magnus Löndahl, MD, PhD
Hyperbaric Oxygen Therapy (HBOT) is a potential tool for management of hard to heal wounds. Critical analysis of the HBOT database will help the attendee practically apply this information to patient care.

 

SESSION 22: Delivery of Wound Care

Criminalization of Adverse Events: What Healthcare Providers Need to Know
Moderator/Speaker: Caroline E. Fife, MD
Speakers: Joy Schank, RN, MSN, ANP, CWOCN; Kevin W. Yankowsky, JD
Did Conrad Murrray murder Michael Jackson or did he commit malpractice? While this high profile case represents an extreme situation, there is a trend toward the “criminalization” of medical adverse events, in particular, the development of pressure ulcers. Session presenters will use actual cases to illustrate key points. 

SESSION 23: Research to Practice
Omics Technology: Hypothesis-generating Technology
Moderator/Speaker: Sashwati Roy, PhD
Speakers: Christopher J. Lengner, PhD; Lillian B. Nanney, PhD; Marjana Tomic-Canic, PhD
High-throughput “omics” technologies (e.g., genomics, epigenomics, proteomics, metabolomics) offer exciting opportunities for global biological insights into wound and stem cell biology with potential for translation into clinical tests useful for prediction of wound outcome and optimization of therapies. The session will be interactive with didactic lectures from leading experts followed by questions from attendees. 

BREAK 11:30 a.m.–11:45 a.m.

 

LUNCH WITH EXHIBITS 11:45 a.m.–2:15 p.m.

 

AAWC/WHS Meet the Mentors 12:15 p.m.–2:15 p.m.

 

2:15 p.m.–3:15 p.m. (7 concurrent sessions — choose one)

 

SESSION 24: Core Clinical

Pressure Ulcers and Surgical Site infections: Are they "Never Events" and How to Deal With Them?
Moderator/Speaker: Harriet W. Hopf, MD
Speaker: Margie Fortino, MSN, RN
Surgical site infections and pressure ulcers have been identified by CMS as Hospital Acquired Conditions (HACs), are sometimes incorrectly identified as "Never Events” that are reasonably preventable by proper care, and have a major negative outcome. This session will explore the following questions: What can be done to prevent HACs? What can be done when the event truly wasn't preventable?

SESSION 25: Advanced Clinical
Practical Burn Treatment for the Non-Burn Clinician
Moderator/Speaker: Paul Silverstein, MD
Speaker: David G. Greenhalgh, MD, FACS
This session will teach burn care essentials from the time of injury through discharge from the clinic. Emphasis will be placed on the role of the first responder, basic triage, wound evaluation, and fluid resuscitation. Various treatment modalities of partial and full thickness burn injuries will be presented. This session will provide practical strategies on how to choose the best course of treatment for optimal patient outcomes, and also explore pediatric burns and why kids are not “little adults.”

Supported by an educational grant from Molnlycke Health Care, US LLC

SESSION 26: Wound Therapeutics

Biomatrices: Evidence and Theory
Moderator/Speaker: Gerit Mulder, DPM, MS, PhD(c), FRCST, FAPWCA
Speaker: Chandra Nataraj, PhD
This session will address the potentials and limitations of the different biomatrices that are currently available in the market to satisfy challenges in the wound environment. The structural and material properties of these products, as well as their clinical use in addressing chronic wounds will be discussed from scientific and clinical perspectives. No single biomatrix is capable of addressing all or even the majority of the needs of chronic wound treatments. Therefore, this presentation will also discuss possible combinations of therapies to achieve desired outcomes.

 

SESSION 27: Limb Preservation

Endovascular Approaches to limb Salvage
Moderator/Speaker: Subodh Arora, MD
Speaker: Shawn Sarin, MD
This session will discuss optimal ways to revascularize the lower limb. 

 

SESSION 28: Delivery of Wound Care

Healthcare Reform — What Does the Future Hold?
Moderator/Speaker: Marcia Nusgart, R.Ph
Since March 2010, when the Affordable Care Act became law, what provisions have impacted wound care physicians, clinicians and wound care clinics and hospitals? Learn about how such new organizations created under healthcare reform, such as the Patient Care Outcomes Research Institute and the Center for Medicare and Medicaid Innovation, may impact your wound care practice. Presenters will also discuss initiatives such as comparative effectiveness, accountable care organizations, fraud and abuse provisions, patient care models and payment bundling. They will also discuss how you can keep up with the information and discern how these initiatives will affect the way you practice wound care.

 

SESSION 29: Research to Practice

Emerging Insights on Scarring and Scar Treatment
Moderator/Speaker: Thomas Mustoe, MD
Speaker: Bernard Coulomb, PhD
Current therapies for scarring are limited. New directions for reduction in scarring come from insights gained from mucosal healing where scarring is limited, and as a corollary, the role of the epidermis. This session will explore recent investigational approaches, including a review of clinical trials with basis for mechanism of action.

 

WHS Program: Session D

International Session —Organized by the European Tissue Repair Society
Tissue Repair: From Basic Science to Translational Medicine
Moderator: Sabine Eming, MD
Speakers: Jean-Jacques Lataillade, MD, PhD; Tanya J. Shaw, MD; Sabine Werner, PhD
This session will discuss common and different molecular and cellular mechanisms between wound healing and cancer. Presenters will also investigate what is the status quo of cell therapy in degenerative and tissue destructive diseases and what are the advantages/risks compared to other therapeutic options in regenerative medicine. How epigenetic mechanisms impact tissue repair and how this knowledge could be translated to improve wound healing in the clinic will be explored.

 

BREAK 3:15 p.m.–3:30 p.m.

WHS GENERAL SESSION DAY 2 — Keynote Address

3:30 p.m.–4:30 p.m.

Wound Healing: New Reparative and Regenerative Strategies
Moderator/Speaker: Geoffrey C. Gurtner, MD, FACS
Wound healing is a multifaceted biological process that involves multiple tissue types – both local as well as systemic. This session will first address the key principles in mammalian reparative biology and then address how developments in regenerative medicine may help expedite wound closure. Specific emphasis will be directed towards stem cell biology and the opportunities/ challenges related to stem cell based therapies. The lecture will also address late breaking developments in the area of tissue vascularization in the context of human skin wound healing. 

 

BREAK 4:30 p.m.–4:45 p.m.

 

4:45 p.m.–5:45 p.m. (5 concurrent sessions — choose one)

 

SESSION 30: Oral Abstracts  

SESSION 31: Oral Abstracts 

SESSION 32: Oral Abstracts

 

SESSION 33: AAWC Poster Grand Rounds

(Limited to 75 people – register early)
The AAWC Research Poster Grand Rounds are walking sessions, in which attendees assemble at one of several AAWC educational research posters, are given a brief lecture outlining the key points by one of the AAWC Research Committee members or a board member, and are then escorted to view 2 to 3 specially selected and related posters that have been critiqued by the AAWC’s Research Committee. The educational research posters provide information on how to evaluate and improve methodology of wound research conducted using: the pre-experimental design static group comparisons or cross sectional designs; the pre-experimental design, one group pre-test/post-test design including longitudinal time series and panel designs; quasi-experimental designs including pre-test and post-test nonequivalent group design; time series design; and non-equivalent before and after design. There will also be information on how to present your clinical research/education in a poster presentation with examples of what not to present when developing an effective, methodologically rigorous poster for dissemination of your findings.
Please note: Anyone with limited ability or an inability to walk should be especially alerted that this is a walking session should they need assistance of some kind.

 

WHS Program: Session E

4:45 p.m.–7:00 p.m.

Concurrent mini-symposia 1 and 2 (oral abstracts)

 

BREAK 5:45 p.m.–6:00 p.m.

 

AAWC MEMBERSHIP MEETING 6:00 p.m.–7:00 p.m.

 

POSTER GALA/SAWC AWARDS 7:00 p.m.–8:30 p.m.

 

WHS NEW MEMBER RECEPTION 8:30 p.m.–9:30 p.m.

DAY 3: SATURDAY, APRIL 21, 2012

 

INDUSTRY-SUPPORTED SYMPOSIA

7:30 a.m.–9:00 a.m.

 

BREAK 9:00 a.m.–9:15 a.m.

 

GENERAL SESSION DAY 3: BOSWICK AWARD

9:15 a.m.–10:15 a.m.

John Boswick Memorial Award and Lectureship
2020: What Will We See in Wound Care?
Moderator/Speaker: Elof Eriksson, MD
Speaker: E.J. Caterson, MD
In the past three decades, a number of new wound treatments have been researched and introduced clinically. They include growth factors, skin substitutes, negative pressure wound therapy, topical antimicrobials and other modalities. Some have been very useful but others have not. These modalities and promising treatments on the horizon will be discussed.

 

BREAK 10:15 a.m.–10:30 a.m.

 

10:30 a.m.–11:30 AM  (7 concurrent sessions — choose one)

 

SESSION 34: Core Clinical

Moisture Associated Skin Damage: If It Is On The Butt, What is it?Moderator/Speaker: Evonne Fowler, RN, CNS, CWON
Speaker: Karen Lou Kennedy-Evans, RN, FNP, APRN-BCThis session will include an overview on the epidemiology, primary causes, and clinical course of moisture associated skin damage, its relationship to pressure ulcer formation and risk, and distinctive characteristics and management.  

 

SESSION 35: Advanced Clinical

The Foot: Gait Analysis and Offloading
Moderator/Speaker: Jim McGuire, DPM, PT, CPed, FAPWCA
Speakers: Gregory Bohn, MD, FACS; Kendrick Whitney, DPM, FAPWCA
This session will address the evidence for interventions to offload the diabetic foot and will emphasize available comparative effectiveness data to use in the decision making process when choosing between modalities to offload the wounded extremity. The data supporting the effectiveness of the total contact cast will be contrasted with a transitional approach to the foot offloading that incorporates offloading walkers as well as footwear based devices. Once the wound is closed, an evidence-based strategy for maintaining a wound-free foot using available footwear will be presented. 

 

SESSION 36: Wound Therapeutics

Cell Therapy Today and Tomorrow
Moderator/Speaker: Vincent Falanga, MD, FACP
Cell therapy has the advantage of providing a “smart” solution to the problem of non-healing or impaired wounds. In engineering terms, “smart” generally refers to a therapy or device that is capable of adapting to its microenvironment in terms of producing growth factors/cytokines, developing a proper wound substrate, and stimulating the endogenous process of wound healing. This session will address the advantageous role of cell therapy in wounds. 

 

SESSION 37: Limb Preservation

Podiatric Surgery: Understanding Why and How
Moderator/Speaker: John S. Steinberg, DPM, FACFAS
Speaker: Paul Kim, DPM
This session will examine the role of podiatric surgery in the wound care patient setting. The focus will include biomechanical procedures for the purpose of prophylactic and curative outcomes in the patient with diabetic foot complications.

 

SESSION 38: Delivery of Wound Care

Creating the Future of Wound Care: Building Future leaders
Moderator/Speaker: William H. Eaglstein, MD
Speakers: Elof Eriksson, MD; Thomas K. Hunt, MD, FACS, DMHC, FRCS; Katherine F. Jeter, EdD, ET
Senior leaders in the wound healing community will present their experience and techniques for identifying, attracting, mentoring and promoting “students and followers” to become leaders in the field of wound care and wound healing. 

 

SESSION 39: Research to Practice

Diabetic Foot Ulcers: Cutting Edge Science Leading To Clinical Application
Moderator/Speaker: Geoffrey C. Gurtner, MD, FACS
Speaker: William J. Ennis, DO, MBA, FACOS
Improving clinical care requires both innovation and evidence-based medicine but at times, these goals can be at odds especially with new technology. Before there can be multiple large trials that clinicians and third party payers require, there are smaller “first in man” and early phase trials in which the evidence is much less compelling. This problem will be explored in the context of DFUs as there are many new and exciting technologies on the horizon with varying degrees of clinical evidence. 

 

WHS Program: Session F

10:30 a.m.–11:30 a.m.
Inducible Pluripotent Stem (iPS) Cell Technology
Moderators: Jeffrey M. Davidson, PhD; Lillian B. Nanney, PhD
Speakers: Christopher J. Lengner, PhD; Tongbiao Zhao, PhD
This session will feature three lectures. The first lecture will present a summary of the iPS technology platform including nuclear reprogramming, and the advantages of iPS over embryonic stem cell platform. The second lecture will address the experimental use of iPS and function outcomes. The third lecture will review emergent approaches for iPS based therapies and their clinical relevance.

 

BREAK 11:30 a.m.–11:45 a.m.

 

WHS Program: Session G

11:45a.m.–12:45 p.m.

Vascular Biology
Moderators: Paul Liu, MD; Aamir Siddiqui, MD
Speakers: Christopher Attinger, MD, FACS; Luisa DiPietro, DDS, PhD; Elof Eriksson, MD
This session will feature three lectures. The first lecture will review the angiogenic and angiostatic factor relevant to the wound site. The second lecture will address angiogenesis directed therapeutic strategies and cautionary remarks. The final lecture will address whether targeting angiogenesis alone is sufficient to close a human chronic wound, and what are the additional considerations. 

LUNCH WITH EXHIBITORS/COMMITTEE MEETINGS FOR WHS
11:45 a.m.– 2:15 p.m. 

WHS GENERAL SESSION: Day 3

2:15 p.m.–3:15 p.m.
Inflammation
Moderators: Adrian Barbul, MD; Manuela Martins-Green, PhD
Speakers: David G. Greenhalgh, MD, FACS; S. Joseph Leibovich, PhD; Saswati Roy, PhD
Inflammation is an early response that sets the stage for subsequent wound healing. For healthy wound healing, mounting as well as resolving inflammation are equally important. Unresolved inflammation complicates wound healing and must be managed. This session will feature three short talks. The first will address the process of inflammation and the key players involved. The second talk will address resolution of inflammation and related complications in the setting of diabetic wounds. The third talk will address therapeutic strategies targeting suppression of excessive unresolved inflammation. 

 

BREAK 3:15 p.m.–3:30 p.m.

 

3:30 p.m.–4:30 p.m. (4 concurrent sessions — choose one)

 

SESSION 40: Oral Abstracts

SESSION 41: Oral Abstracts

SESSION 42: Oral Abstracts

 

WHS Program: Session H

3:30 p.m.–5:30 p.m.

Concurrent mini-symposia 3, 4, and 5 (oral abstracts)

 

BREAK 4:30 p.m.– 4:45 p.m.

 

4:45 p.m.– 5:45 p.m. (6 concurrent sessions — choose one)

 

SESSION 43: Core Clinical

Negative Pressure Wound Therapy: Can Everyone Be Wrong?Moderator/Speaker: Laura Bolton, PhD
Speaker: David G. Armstrong, DPM, MD, PhDYou’ve heard the controversies about NPWT. Come hear the science. What types of wounds respond favorably? How and when does one apply NPWT to optimize safety and efficacy? How do NPWT systems compare to each other or to other interventions in achieving wound outcomes? Learn the facts for your practice!

Supported by an educational grant from Spiracur, Inc.

 

SESSION 44: Advanced Clinical

AAWC Global Volunteers
Moderator/Speaker: Thomas E. Serena, MD, FACS, MAPWCA, FACHM
Speakers: Terry Treadwell, MD, FACS; TBD
The HVO/AAWC Global volunteer program continues to serve the needs of the world’s wounded. This session will focus on the mission of the program, the responsibilities of the volunteer, and the “nuts and bolts” for volunteering. Lecturers will include their firsthand experience in volunteering in resource poor countries.

 

SESSION 45: Wound Therapeutics

Therapeutic Considerations for the Spinal Cord Injury Patient
Moderator/Speaker: Barbara Bates-Jensen, PhD, RN, FAAN
Speaker: Barry Goldstein, MD, PhD
The high rate of pressure ulcer recurrence and the severity of recurrent pressure ulcers in the spinal cord injury (SCI) population present a significant challenge to health care professionals. Pressure ulcers in persons with SCI, while similar to other high-risk populations, have some important differences. Standard risk assessment is not effective in persons with SCI and prevention efforts must be focused differently. As most pressure ulcers in persons with SCI are community acquired, prevention must be targeted on early detection, behavior change strategies, and social networks. This session will examine the pathophysiology of pressure ulcer development in the patient with SCI and issues specific to this population including: recurrence, altered anatomy, risk assessment, and prevention. This session will also explore the emergence of the Pressure Ulcer Monitoring Tool (PUMT), a useful tool developed for monitoring ulcer status on persons with SCI in the VA Healthcare System. Discussion of areas where evidence is needed to assist in moving the quality of care forward for this vulnerable population will be outlined as a call for future research. 

 

SESSION 46: Limb Preservation

Plastic Surgical Repair of Chronic Wounds
Moderator/Speaker: Christopher Attinger, MD, FACS
Speaker: Karen Kim Evans, MD, FACS
Simple (delayed primary closure, skin graft or local flaps) and more complex (pedicle or microsurgical flaps) surgical techniques can be used to close wounds. The choice depends on functional outcome, patient condition and surgical skills. This session will provide wound care personnel enough information to participate in the decision making process. 

 

SESSION 47: Delivery of Wound Care

Special Circumstances in Wound Care: Pediatric and Geriatric Wound Care
Moderator/Speaker: Teri Robinson, RN, BSN, CWON
Speaker: Marco Romanelli, MD, PhD
At both ends of the life span, pediatric and geriatric wound care require specialized knowledge and skills. Unique challenges are examined, including acute neonatal wounds and pressure ulcers with spina bifida patients. Presenters will also review wound bed preparation and analyze dimensional and chromatic parameters of chronic geriatric wounds. 

 

SESSION 48: Research to Practice

What to Use and When: Comparative Effectiveness Research
Moderator/Speaker: Susan D. Horn, PhD
Speaker: Caroline Fife, MD
This session will provide an understanding of study designs and databases that can be used for comparative effectiveness research and their advantages and limitations to determine better treatments for specific types of wounds and patients. Various methods to assess validity of findings will be discussed. 

 

WHS Program — Wound Healing Foundation/3M Award  5:45 p.m.–6:15 p.m.

 

BREAK 6:15 p.m.–6:30 p.m.

 

WHS BUSINESS MEETING  6:30 p.m.–7:30 p.m.

  

WHS MEMBER AND GUEST RECEPTION  7:30 p.m.– 10:00 p.m.

 

DAY 4: SUNDAY,  APRIL 22, 2012

 

Industry-Supported Symposia     7:30 a.m.–9:00 a.m.

 

WHS Program: Session I

8:00 a.m.–10:00 a.m.

Concurrent mini-symposia 6 and 7 (oral abstracts)

 

9:15 a.m.–10:15 a.m. (6 concurrent sessions — choose one)

 

SESSION 49: Core Clinical

Venous Ulcers: What's New
Moderator/Speaker: Sabine Eming, MD
Speakers: Magnus Agren, PhD; Karin Scharffetter-Kochanek, MD
Venous insufficiency is the major cause underlying chronic skin ulcers. Yet the molecular mechanisms and how venous insufficiency translates into pathological alterations of skin function and ultimately ulceration are not understood. This session will discuss recent advances on the molecular pathology of venous ulcers and their implications for the development of novel therapeutic strategies. 

 

SESSION 50: Advanced Clinical

Understanding Geriatric Skin and Wounds of the Elderly
Moderator/Speaker: Karen Lou Kennedy-Evans, RN, CS, FNP
Speaker: Olivera Stojadinovic, MD
In this session, attendees will explore the underlying physiology, histology and predisposing factors of skin problems in the elderly. Discussion will include an approach to managing common skin conditions, particularly those that may predispose to skin ulceration in this population. 

 

SESSION 51: Wound Therapeutics

Wound Scene Investigation 1
Moderator/Speaker: Dot Weir, RN, CWOCN, CWS
Speakers: Robert Diegelmann, PhD; Lisa Gould, MD, PhD; Lillian B. Nanney, PhD; Gregory Schultz, PhD
Clinicians are frequently challenged with wounds that fail to heal, or wounds that eventually do heal, but for which the mechanism of healing is unclear. In this popular session, returning for a fifth year, a panel of clinicians and scientists will examine real cases and provide clues as to what may have been the barriers to healing, and provide potential interventions to overcome them. 

 

SESSION 52: Limb Preservation

Functional Impairments: Impact on Wounding and Healing
Moderator /Speaker: Heather Hettrick PT, PhD, CWS, FACCWS, MLT, DAPWCA
Speaker: Rose Hamm, DPT, CWS
Functional impairments affect people across the lifespan and may result from various disease states, traumatic injuries or other medical complexities. Such patients can pose a unique challenge to the wound care provider. This session will focus on functional impairments, how they may contribute to skin problems/wound healing, and treatment of functional impairments to improve wound healing potential.

 

SESSION 53: Delivery of Wound Care

Beyond PowerPoint: Modern Techniques in Wound Care Education
Moderator/Speaker: Lia van Rijswijk, RN, MSN, CWCN
Speaker: Janice M. Beitz, PhD, RN, CS, CNOR, CWOCN, CRNP
Compelling evidence overwhelmingly supports the benefits of active learning for long-term educational outcomes. Wound educators should be encouraged to utilize a repertoire of teaching techniques that promote active learning. This session will demonstrate how clinicians can “HAM” (humor, analogy, metaphor) it for optimal wound care education.

 

SESSION 54: Research to Practice

Design and Assessment of Functional Biomaterial Based Wound Healing Therapies and Imaging
Moderator/Speaker: Abhay Pandit, PhD
Speaker: Kishore Bhakoo, PhD
This session will present strategies to design the next generation of regenerative therapies that engage the host. Understanding the pathology is key to designing impactful interventional strategies. With these interventional strategies, the challenge of assessment becomes compounded. This session will also present the latest advances in molecular imaging tools that can be used to assess regenerative responses associated with these therapies.

BREAK 10:15 a.m.–10:30 a.m. 

10:30 a.m.–11:30 a.m.(7 concurrent sessions — choose one)

 

SESSION 55: Core Clinical

Complex Wounds in the Acute Care Setting
Moderator/Speaker: C. Tod Brindle, BSN, RN, ET, CWOCN, CLIN IV
Speaker: Jacob Swenson, MSN, RN, CCRN
The acute care setting challenges the wound care practitioner to triage, prioritize necessity, develop a plan of care, and prepare a patient for discharge. Wounds involving a large total body surface area, including burns, present unique challenges for the burn clinician and wound healing expert. In addition, the complex surgery patient requires creativity and holistic care considerations. This presentation will discuss wound bed preparation, skin graft protection, chronic wound management and assessment of complex wounds in the acute care setting.

 

Supported by an educational grant from Molnlycke Health Care, US LLC 

SESSION 56: Advanced Clinical

Highlights from Recent Wound Literature
Moderator: Luisa DiPietro, DDS, PhD
Speakers: Prof. Alexis Desmoulière; Sabine Werner, PhD
New articles about wound healing are published at the astounding rate of nearly 5,000 each year! This session will highlight hot topics as well as novel technologies in the study of wound healing in health and disease. Presenters will explore how these new discoveries could influence clinical care. 

 

SESSION 57: Wound Therapeutics

Wound Scene Investigation 2
Moderator/Speaker: Dot Weir, RN, CWOCN, CWS
Speakers: Robert Diegelmann, PhD; Lisa Gould, MD, PhD; Lillian B. Nanney, PhD; Gregory Schultz, PhD
Using a case study approach, this session will continue the themes of Wound Scene Investigation with an interdisciplinary faculty panel examining challenging cases from a clinical and basic science perspective.

 

SESSION 58: Limb Preservation

Life Post Amputation: Implications for Care
Moderator/Speaker: Robert Gailey, PhD, PT
Speaker: John R. Fergason, CPO
The majority of people with limb loss in the United States suffered an amputation related to vascular disease with or without diabetes and trauma. The prescription of prosthetic devices is an important consideration not only for the replacement of limbs but also in prevention of post-operative healing complications, contralateral limb loss and the reduction of long term secondary conditions. This presentation will discuss the criteria and clinical evaluation procedures for the prescription of prosthetic limbs for the dysvascular and traumatic amputee populations. Separating the myths from the facts, there will be an emphasis on the scientific evidence related to functional capabilities of prosthetic sockets, knee and foot designs.

 

SESSION 59: Delivery of Wound Care

Social Networking for the Wound Care Provider
Moderator/Speaker: William Li, MD
Speakers: Desmond Bell, DPM, CWS; Thomas E. Serena, MD, FACS, MAPWCA, FACHM
Social media is redefining communications and interactions between health providers and among patients. Tools such as Facebook, Twitter, Google Plus, and YouTube enable keystroke access to health information. This session provides an overview of how social media is entering the wound care field, and describes its benefits and challenges to improving patient outcomes.

 

SESSION 60: Research to Practice

Stem Cells for Wound Therapy
Moderator/Speaker: Evangelos V. Badiavas, MD, PhD
This session will focus on novel ways, under investigation, to improve wound healing through the use of stem cells.

 

WHS Program: Session J

Yin-Yang of Wound Healing: Understanding the Differences to Arrive at a Common good
Joint session with the veterinary Society for Wound Management
Moderators: Bonnie Grambow Campbell, DVM, PhD; Laura K.S. Parnell, BSc, MSc, CWS
Speakers: Mark W. Bohling, DVM, PhD; Christine Theoret, DMV, PhD; Susan Volk, VMD, PhD
This session will explore the extremes of mammalian wound healing as well as future directions. Clinical examples and research models of delayed healing and exuberant tissue deposition will be presented. Use of stem cell therapy models/trials to modulate wound healing will also be presented. Correlation of animal wound healing to human healing will be a common theme for each speaker. A panel discussion will conclude the session allowing participants to specifically inquire about models or problems in wound healing.

 

BREAK 11:30 a.m.–11:45 a.m.

, APRIL 22, 2012or

GENERAL SESSION: Day 4

11:45 a.m.–12:45 p.m.

Diagnostics and Theranostics: The Future is Here
Moderator/Speaker: Thomas E. Serena, MD, FACS, MAPWCA, FACHM
Speaker: Gregory Schultz, PhD
This session will review the current status of diagnostics in the field of wound care. Led by a pioneer in this field, this session will bring attendees up-to-date on current investigation in the field. Session presenters will highlight their research on the development of inflammatory and bacteria diagnostics. “Diagnostics will result in a tectonic shift in the practice of wound care in the near future.” — Dr. T.E. Serena. 

 

LUNCH ON OWN 12:45 p.m.–1:30 p.m.

 

POST-CONFERENCE

1:30 p.m.–4:30 p.m. (3 concurrent sessions — choose one)

 
SESSION 61: 2012 Reimbursement Challenges for Physicians, Podiatrists, Non-Physician Practitioners, and Outpatient Wound Care Departments
Moderator/Speaker: Kathleen D. Schaum, MS
Speaker: Donna Cartwright, MPA, RHIA, CCS, RAC, FAHIMA
This workshop will focus on medical professionals and outpatient wound care departments that 1) are paid via the Medicare Physician Fee Schedule and the Medicare Outpatient Prospective Payment System, 2) are managing patients with wounds in various sites of service, and 3) are now participating in or are considering participation in an Accountable Care Organization (ACO). The attendees will learn the 2012 coding, payment, and coverage changes that are important to wound care professionals and how to take an active wound management coordination role in the ACOs that will be managing patient care in various sites of service and will be looking to wound care professionals to provide the most cost-effective care. Finally, the attendees will learn how to maintain compliance while working in both the traditional Medicare fee-for-service program and the ACOs. Attendees will receive a handbook that contains current 2012 coding, payment, and coverage information.

 
SESSION 62: Comprehensive Hands-On Debridement Skills Lab
Moderator/Speaker: Pamela Scarborough, PT, MS, CDE, CWS, FACCWS
Speaker: Gregory K. Patterson, MD, FACS, CWS
This course was developed for healthcare providers to learn safe and effective methods of debridement. Debridement can be accomplished surgically (instrument/sharp), chemically with enzymes, mechanically, biologically with the use of maggot therapy, or by autolysis. Each modality has advantages, disadvantages, indications for use, and risks. A review of anatomy and physiology, legal and safety factors, potential complications, and techniques of debridement will be presented. Debridement techniques will be practiced in a skills lab setting. Sharp debridement will be practiced using porcine models. Upon completion of this course, a certificate of attendance will be awarded.

SESSION 63: Offloading And Total Contact Casting Techniques
Moderator/Speaker: Larry Lavery, DPM, MPH
Speaker: Javier La Fontaine, DPM, MS
This session will discuss the medical evidence and rationale for offloading and wound healing in the diabetic foot, demonstrate total contact casting techniques and different commercially available removable boots to offload the foot, and the application of healing sandals.

REGISTER NOW!